2012
DOI: 10.1097/coc.0b013e3182195619
|View full text |Cite
|
Sign up to set email alerts
|

The Prognostic Importance of Midline Involvement in Oral Tongue Cancer

Abstract: Objectives To examine the importance of midline involvement and other clinicopathological factors in predicting the rate of contralateral lymph node metastasis and survival in oral tongue squamous cell carcinoma. Methods We used SEER data to identify a cohort of 5430 patients with laterally rising tumors. Clinicopathological factors examined as potentially predictive of contralateral lymph node metastasis included extension to midline, T classification, anatomical site, grade, histological sub-type, race, ag… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
12
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(14 citation statements)
references
References 23 publications
2
12
0
Order By: Relevance
“…In this study of TSCC, the incidence of CLNM was as high as 34.4% (11 of 32 patients), presumably because the subjects were limited to locally advanced stage cT3–4a tumors. In line with this, among previous studies that confined the subjects to laterally arising TSCC, a study that screened all stages using a population-based cancer registry, in which cT1–2 constituted 70% of the cohort, showed a very low CLNM incidence of 2.5% ( 10 ). In contrast, a study that exclusively analyzed patients with primary tumors that crossed the midline, in which cT3–4 constituted 82% of the cohort, reported a relatively high CLNM incidence of 29.2% ( 24 ).…”
Section: Discussionsupporting
confidence: 55%
See 4 more Smart Citations
“…In this study of TSCC, the incidence of CLNM was as high as 34.4% (11 of 32 patients), presumably because the subjects were limited to locally advanced stage cT3–4a tumors. In line with this, among previous studies that confined the subjects to laterally arising TSCC, a study that screened all stages using a population-based cancer registry, in which cT1–2 constituted 70% of the cohort, showed a very low CLNM incidence of 2.5% ( 10 ). In contrast, a study that exclusively analyzed patients with primary tumors that crossed the midline, in which cT3–4 constituted 82% of the cohort, reported a relatively high CLNM incidence of 29.2% ( 24 ).…”
Section: Discussionsupporting
confidence: 55%
“…Previous studies have reported an incidence of CLNM in OSCC ranging from 0.9% to 36% ( 9 , 10 , 22 24 , 27 31 ). Such wide variance seems to be attributable primarily to differences in patient eligibility criteria in terms of anatomic subsites, location, and stage of the tumor, as well as disparity in standard treatment strategies and histopathological processing at each institution.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations